EUVIMEDEUVIMED entdecken
Crossref

CAR-T Cell-Based Immunotherapy

Cailynn

INFM-OAR (INFN Catania) · 15.08.2023

DOI: 10.15161/oar.it/77176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift INFM-OAR (INFN Catania), erschienen am 15.08.2023. Verfasst von Cailynn.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past decade, great progress has been made in the field of immunotherapy, especially in the field of T cell therapy. Chimeric antigen receptor (CAR)-engineered T cell therapy is the most promising approach, which has shown remarkable ability in the elimination of a variety of tumors.

Schlagwörter

CAR T-cell therapychimeric antigen receptorT cell engineeringcancer immunotherapytumor eradication

Zitieren

APA

Cailynn (2023). CAR-T Cell-Based Immunotherapy. INFM-OAR (INFN Catania). https://doi.org/10.15161/oar.it/77176

Vancouver

Cailynn. CAR-T Cell-Based Immunotherapy. INFM-OAR (INFN Catania). 2023. doi:10.15161/oar.it/77176

BibTeX
@article{Cailynn2023,
  author = {Cailynn},
  title = {CAR-T Cell-Based Immunotherapy},
  journal = {INFM-OAR (INFN Catania)},
  year = {2023},
  doi = {10.15161/oar.it/77176}
}
Kostenlos starten →